The introduction of nicotinamide as being a nicotine alternative in e-cigarette and smokeless merchandise signifies a substantial regulatory obstacle for your FDA. Nicotinamide does not have nicotinic receptor agonist action and is known to work as a sedative at high dosages6. The statements produced by Nicotine River, ECBlend, and various supplier